The investigation is designed as an open, randomized, non-inferiority, multi-centre investigation.
212 evaluable subjects will be randomised. Subjects to be included will suffer from an exuding venous or mixed ulcer of predominantly venous origin. Subjects will either be randomized to Exufiber or Aquacel Extra using centralized randomization
Visits are planned for baseline followed by 1, 2, 3, 4 and 6 weeks post treatment. The sub-group of at least 50 subjects will also be followed at week 8, 12, 16, 20, and 24 post treatment or until wound is healed if earlier.
|Treatment||Aquacel Extra, Exufiber|
|Clinical Study Identifier||NCT02921750|
|Sponsor||Molnlycke Health Care AB|
|Last Modified on||4 November 2020|
Select a piece of text and start making personal notes.
Congrats! You have your own personal workspace now.